EQUIC-CC: Enhancing Quality of Informed Consent - Customized Consent
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Patients in 'parent' cooperative study projects are interviewed about their experiences in the informed consent process.
| Condition |
|---|
|
Healthy |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Crossover Time Perspective: Retrospective |
| Official Title: | CSP #476CC - Enhancing Quality of Informed Consent (EQUIC-CC) Customized Consent |
- improve method of disclosing information to patients in the informed consent process [ Time Frame: post-randomization ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 240 |
| Study Start Date: | April 1999 |
| Study Completion Date: | April 1999 |
| Primary Completion Date: | April 1999 (Final data collection date for primary outcome measure) |
Detailed Description:
Intervention: (1) Cognitive stratification (obtained by a test of cognitive ability, followed by a tailored IC process); (2) Pre-recruitment video (a patient-activation video designed to prevent several common misconceptions; (3) Provide prospective research volunteers with a sense of the purpose and methods of controlled research); and (4) Evaluation of the informed consent process using the Brief Informed Consent Evaluation Protocol (BICEP) developed in EQUIC-DP.
Primary Hypothesis: The validity of informed consent can be improved, as measured by an independent interview of patients (BICEP), by at least one of three interventions described above.
Primary Outcomes: The quality of the informed consent process, as measured by the BICEP (Brief Informed Consent Evaluation Protocol). The BICEP also offers a method to certify informed consent in routine use.
Study Abstract: Customized Consent will develop and test an innovative, supplemental method of disclosing information to patients in the informed consent process. This disclosure strategy is intended to increase patients' understanding and satisfaction with the consent process. This study has two goals:
- to evaluate the effectiveness of an intervention to improve comprehension during informed consent; and
- to identify those patients for whom this intervention is most effective.
The primary goal of EQUIC-CC is to determine whether an intervention, added to usual procedures for obtaining informed consent, is able to improve comprehension. The second goal of EQUIC-CC is to identify those patients for whom an augmented consent intervention is most effective, as well as to determine which subgroups of patients, if any, are most likely to benefit from visual information added to the usual disclosure phase of obtaining informed consent.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Veterans in selected clinical trials conducted by VA
Inclusion Criteria:
Inclusion Criteria:
- Depends on 'parent' study
Exclusion Criteria:
Exclusion Criteria:
- Depends on 'parent' study
Contacts and Locations| United States, California | |
| VA Palo Alto Health Care System | |
| Palo Alto, California, United States, 94304-1290 | |
| Stanford University | |
| Stanford, California, United States, 94305 | |
| United States, North Carolina | |
| VA Medical Center, Durham | |
| Durham, North Carolina, United States, 27705 | |
| United States, Pennsylvania | |
| VA Medical Center, Philadelphia | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| Study Chair: | Philip Lavori, PhD | Stanford University |
More Information
No publications provided
| Responsible Party: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00032539 History of Changes |
| Other Study ID Numbers: | 476CC |
| Study First Received: | March 27, 2002 |
| Last Updated: | March 14, 2012 |
| Health Authority: | United States: Federal Government |
Keywords provided by Department of Veterans Affairs:
|
Informed Consent |
ClinicalTrials.gov processed this record on May 16, 2013